Tartaglia, Marco
 Distribuzione geografica
Continente #
NA - Nord America 2.775
EU - Europa 1.713
AS - Asia 1.331
SA - Sud America 279
Continente sconosciuto - Info sul continente non disponibili 58
AF - Africa 46
OC - Oceania 1
Totale 6.203
Nazione #
US - Stati Uniti d'America 2.695
SG - Singapore 546
PL - Polonia 436
CN - Cina 405
DE - Germania 360
BR - Brasile 222
SE - Svezia 216
UA - Ucraina 161
IT - Italia 151
VN - Vietnam 121
FR - Francia 81
IE - Irlanda 70
GB - Regno Unito 67
ID - Indonesia 45
FI - Finlandia 43
IN - India 42
AT - Austria 36
RU - Federazione Russa 35
JP - Giappone 34
AR - Argentina 23
CA - Canada 23
TR - Turchia 23
IQ - Iraq 20
BD - Bangladesh 18
HK - Hong Kong 14
MX - Messico 14
NL - Olanda 14
CO - Colombia 11
ES - Italia 10
VE - Venezuela 9
CR - Costa Rica 8
IR - Iran 8
SA - Arabia Saudita 8
BE - Belgio 7
CI - Costa d'Avorio 7
JM - Giamaica 7
ZA - Sudafrica 7
CL - Cile 6
KE - Kenya 6
PK - Pakistan 6
HN - Honduras 5
MA - Marocco 5
MY - Malesia 5
UZ - Uzbekistan 5
DO - Repubblica Dominicana 4
EC - Ecuador 4
SV - El Salvador 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
BH - Bahrain 3
DZ - Algeria 3
EE - Estonia 3
EG - Egitto 3
ET - Etiopia 3
IL - Israele 3
KR - Corea 3
LT - Lituania 3
NI - Nicaragua 3
NP - Nepal 3
PT - Portogallo 3
BB - Barbados 2
CG - Congo 2
CH - Svizzera 2
CW - ???statistics.table.value.countryCode.CW??? 2
HR - Croazia 2
JO - Giordania 2
KZ - Kazakistan 2
LY - Libia 2
PA - Panama 2
PH - Filippine 2
PY - Paraguay 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
A1 - Anonimo 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
DM - Dominica 1
GD - Grenada 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
Totale 6.144
Città #
Warsaw 432
Ashburn 309
Singapore 253
Chandler 237
San Jose 206
Fairfield 149
Woodbridge 136
Seattle 109
Jacksonville 102
Nanjing 83
Wilmington 83
San Mateo 71
Dublin 69
Houston 69
Beijing 67
Cambridge 64
Ann Arbor 53
Dearborn 50
Jakarta 40
Ho Chi Minh City 38
Council Bluffs 37
Lauterbourg 37
Vienna 34
Boston 32
Redmond 32
Nanchang 30
New York 28
Hanoi 27
Los Angeles 27
Tokyo 27
Rome 26
Lawrence 25
Frankfurt am Main 23
Hefei 23
Santa Clara 22
São Paulo 22
Chicago 19
Milan 18
Nürnberg 18
Buffalo 17
Moscow 17
Cattolica 16
Brooklyn 15
Dong Ket 15
Izmir 15
Munich 15
Redwood City 15
Hangzhou 14
London 14
Princeton 14
Hong Kong 13
Bremen 12
Phoenix 12
Hebei 11
Jiaxing 11
Dallas 10
Kunming 10
Atlanta 9
Changsha 9
Guangzhou 9
Helsinki 9
Philadelphia 9
Shanghai 9
Shenyang 9
Baghdad 8
Belo Horizonte 8
University Park 8
Abidjan 7
Marseille 7
Norwalk 7
San Francisco 7
San José 7
Tianjin 7
Boardman 6
Brussels 6
Caracas 6
Kent 6
Lancaster 6
Nairobi 6
North Bergen 6
Nuremberg 6
Orem 6
Providence 6
Rio de Janeiro 6
Stockholm 6
Tampa 6
Amsterdam 5
Bogotá 5
Düsseldorf 5
Kingston 5
Mountain View 5
Newark 5
Paris 5
Porto Alegre 5
Queens 5
San Diego 5
Shahid 5
Tashkent 5
Washington 5
Andover 4
Totale 3.649
Nome #
CHK1-targeted therapy to deplete DNA replication- stressed, p53-deficient, hyperdiploid colorectal cancer stem cells 458
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer 348
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer 318
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma 301
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma 295
Enhanced human brain associative plasticity in Costello syndrome 239
Increased sleep spindle activity in patients with Costello syndrome (HRAS gene mutation) 210
Increased sleep spindle activity in patients with Costello syndrome (HRAS gene mutation) 198
A RESTRICTED SPECTRUM OF NRAS MUTATION CAUSES NOONAN SYNDROME 168
Long Term Memory Profile of Disorders Associated with Dysregulation of the RAS-MAPK Signaling Cascade. 168
Structural, Functional, and Clinical Characterization of a Novel PTPN11 Mutation Cluster Underlying Noonan Syndrome 153
Novel SEC61G-EGFR fusion gene in pediatric ependymomas discovered by clonal expansion of stem cells in absence of exogenous mitogens 152
Dystonia in Costello syndrome 150
Cancer stem cell-based models of colorectal cancer reveal molecular determinants of therapy resistance 150
Biallelic SQSTM1 mutations in early-onset, variably progressive neurodegeneration 148
Diversity parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome 139
Noonan syndrome: clinical aspects and molecular pathogenesis. 138
A Specific Mutational Signature Associated with DNA 8-Oxoguanine Persistence in MUTYH-defective Colorectal Cancer. 137
Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy 132
Transcriptional hallmarks of Noonan syndrome and Noonan-like syndrome with loose anagen hair 131
Differential Effects of HRAS Mutation on LTP-Like Activity Induced by Different Protocols of Repetitive Transcranial Magnetic Stimulation 127
GAIN-OF-FUNCTION SOS1 MUTATIONS CAUSE A DISTINCTIVE FORM OF NOONAN SYNDROME. 125
SOS1 mutations in Noonan syndrome: molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlations. 125
Congenital immunodeficiency in an individual with Wiedemann–Steiner syndrome due to a novel missense mutation in KMT2A 125
Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome 121
Cancer stem cell-based models of colorectal cancer reveal molecular determinants of therapy resistance 119
Activating PTPN11 mutations play a minor role in pediatric and adult solid tumors 113
Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype. 111
CRANIOSYNOSTOSIS IN PATIENTS WITH NOONAN SYNDROME CAUSED BY GERMLINE KRAS MUTATIONS 110
Spectrum of MEK1 and MEK2 gene mutations in cardio-facio-cutaneous syndrome and genotype -phenotype correlations. 104
MUTATION OF SHOC2 PROMOTES ABERRANT PROTEIN N-MYRISTOYLATION AND CAUSES NOONAN-LIKE SUNDROME WITH LOOSE ANAGEN HAIR. 103
Germline missense mutations affecting KRAS Isoform B are associated with a severe Noonan syndrome phenotype 102
NF1 gene mutations represent the major molecular event underlying Neurofibromatosis-Noonan syndrome 101
GERMLINE BRAF MUTATIONS IN NOONAN, LEOPARD, AND CARDIOFACIOCUTANEOUS SYNDROMES: MOLECULAR DIVERSITY AND ASSOCIATED PHENOTYPIC SPECTRUM 92
Multiple giant cell lesions in patients with Noonan syndrome and cardio-facio-cutaneous syndrome 90
Exclusion of PTPN1 mutations in Costello syndrome: further evidence for distinct genic etiologies for Noonan, cardio-facio-cutaneous and Costello syndromes 89
absence of PTPN11 mutations in 28 cases of cardiofaciocutaneous (CFC) syndrome. 86
DIVERSITY AND FUNCTIONAL CONSEQUENCES OF GERMLINE AND SOMATIC PTPN11 MUTATIONS IN HUMAN DISEASE 83
Proceeding from the 2009 genetic syndromes of the Ras/MAPK pathway: from bedside to bench and back 82
The italian national genomic strategy: current status, challenges, and future perspectives in clinical practice and public health 29
Multidisciplinary Management of Costello Syndrome: Current Perspectives 18
Solid tumours in RASopathies: insights from a large monocentric cohort and systematic review of the literature 15
Totale 6.203
Categoria #
all - tutte 24.062
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.062


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022243 0 0 0 0 14 17 2 61 13 29 47 60
2022/2023623 84 85 41 87 47 99 21 48 73 12 24 2
2023/2024309 14 103 13 34 6 21 22 8 4 11 31 42
2024/2025560 16 18 49 23 46 19 25 30 74 48 106 106
2025/20261.534 247 45 85 188 237 80 226 89 105 151 48 33
2026/2027537 54 39 126 276 42 0 0 0 0 0 0 0
Totale 6.203